Formulation, Release Characteristics and Bioavailability Study of Oral Monolithic Matrix Tablets Containing Carbamazepine

This study examined the release of carbamazepine (CBZ) from hydrophobic (Compritol® 888 ATO) and hydrophilic-hydrophobic matrix combination (Compritol® 888 ATO-hydroxpropyl methylcellulose, HPMC). Hydrophobic matrix tablets were prepared by hot fusion technique, while hydrophilic-hydrophobic matrix...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Barakat, Nahla S., Elbagory, Ibrahim M., Almurshedi, Alanood S.
Format: Artigo
Langue:Inglês
Publié: Springer US 2008
Sujets:
Research Article/Theme: Oral Controlled Release Development and Technology/Guest Editors: Stephen A. Howard and Jian-Xin Li
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2977049/
https://ncbi.nlm.nih.gov/pubmed/18686038
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1208/s12249-008-9108-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires